Restricted or Expanded Indications for Low-Energy Internal Cardioversion?

  • M. Santini
  • C. Pandozi
  • G. Gentilucci
  • M. Villani


Atrial fibrillation is a very common and potentially dangerous cardiac arrhythmia [1–4]. A 5-fold embolic risk in the non-rheumatic atrial fibrillation and 18-fold risk in the rheumatic group has been ascertained [5] and full anticoagulation is frequently recommended in patients with atrial fibrillation [6–8]. Furthermore the loss of atrial contraction can cause a significant hemodynamic deterioration [9,10]. Restoration of sinus rhythm seems therefore to be advisable.


Sinus Rhythm Coronary Sinus Persistent Atrial Fibrillation Rheumatic Group Restore Sinus Rhythm 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Boysen G, Nyboe J, Appleyard M (1988) Stroke incidence and risk factors for stroke in Copenhagen, Denmark. Stroke 19: 1345–1353Google Scholar
  2. 2.
    Lake FR, Cullen KJ, de Klerk NH, McCall MG, Rosman DL (1989) Atrial fibrillation and mortality in an elderly population. Aust NZ J Med 19: 321–326CrossRefGoogle Scholar
  3. 3.
    Stroke Prevention in Atrial Fibrillation Investigators (1991) Stroke prevention in atrial fibrillation study. Final results. Circulation 84: 527–539CrossRefGoogle Scholar
  4. 4.
    Mogensen L (1993) Fibrillating atria: a sizeable problem, or rather, atrial fibrillation: a striking problem. J Intern Med 233: 373–375PubMedCrossRefGoogle Scholar
  5. 5.
    Wolf PA, Dawber TR, Thomas HE Jr, Kannel WB (1978) Epidemiologic assessment of chronic atrial fibrillation and the risk of stroke: The Framingham study. Neurology 28: 973–977Google Scholar
  6. 6.
    Ezekowitz MD, Bridgers SL, James KE, Carliner LH, Coiling CL, Gornick CC, Krause-Steinrauf H, Kurtezke JF, Nazarian SM, Radford MJ, Rickles FR, Shabetai R, Deykin D (1992) Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation: N Engl J Med 327: 1406–1412PubMedGoogle Scholar
  7. 7.
    Caro JJ, Groome PA, Flegel KM (1993) Atrial fibrillation and anticoagulation: from randomised trials to practice. Lancet 341: 1381–1384PubMedCrossRefGoogle Scholar
  8. 8.
    Ramsay LE (1993) Warfarin in chronic atrial fibrilation. Lancet 341: 1376–1377PubMedCrossRefGoogle Scholar
  9. 9.
    Orlands JR, von Herick R, Aronow WS (1979) Haemodynamics and echocardiograms before and after cardioversion of atrial fibrillation to sinus rhythm. Chest 76: 521–525CrossRefGoogle Scholar
  10. 10.
    Lau CP, Leung WH, Wong CK, Cheng CH (1990) Hemodynamics of induced AF: a comparative assessment with sinus rhythm, atrial and ventricular pacing. Eur Heart J 11: 219–224PubMedGoogle Scholar
  11. 11.
    Pritchett ELC (1992) Management of atrial fibrillation. N Engl J Med 326: 1264–1271PubMedCrossRefGoogle Scholar
  12. 12.
    Levy S, Lacombe P, Cointe R, Bru P (1988) High energy transcatheter cardioversion of chronic atrial fibrillation. J Am Coll Cardiol 12: 514–518PubMedCrossRefGoogle Scholar
  13. 13.
    Levy S, Lauribe P, Dolla E, Kou W, Kadish A, Calkins H, Paganelli F, Moyal C, Bremondy M, Schork A, Shyr Y, Das S, Shea M, Gupta N, Morady F (1992) A randomized comparison of external and internal cardioversion of chronic atrial fibrillation. Circulation 86: 1415–1420PubMedCrossRefGoogle Scholar
  14. 14.
    Murgatroyd FD, Slade AKB, Sopher SM, Rowland E, Ward DE, Camm AJ (1995) Efficacy and tolerability of transvenous low energy cardioversion of paroxysmal atrial fibrillation in humans. J Am Coll Cardiol 25: 1347–1353PubMedCrossRefGoogle Scholar
  15. 15.
    Alt E, Schmitt C, Ammer R Coenen M, Fotuhi P, Karch M, Blasini R (1994) Initial experience with intracardiac atrial defibrillation in patients with chronic atrial fibrillation. PACE 17: 1067–1078PubMedCrossRefGoogle Scholar
  16. 16.
    Kalman JM, Jones EF, Doolan L, Olivier LE, Power JM, Tonkin AM (1995) Low energy endocardial cardioversion of atrial arrhythmias in humans. PACE 18: 1869–1875PubMedCrossRefGoogle Scholar
  17. 17.
    Tang ASL, Yabe S, Wharton JM, Dolker M, Smith WM, Ideker RE (1989) Ventricular defibrillation using biphasic waveforms: the importance of phasic duration. J Am Coll Cardiol 13: 207–214PubMedCrossRefGoogle Scholar
  18. 18.
    Irnich W (1995) Optimal truncation of defibrillation pulses. PACE 18 ( Pt. I): 673–688Google Scholar
  19. 19.
    Ayers GM, Alferness CA, Ilina M, Wagner DO, Sirokman WA, Adams JM, Griffin JC (1994) Ventricular proarrhythmic effects of ventricular cycle length and shock in a sheep model of transvenous atrial defibrillation. Circulation 89: 413–422PubMedCrossRefGoogle Scholar
  20. 20.
    Tomasoni G, Newby KH, Kearney MM, Brandon MJ, Barold H, Natale A (1996) Testing different biphasic waveforms and capacitances: effect on atrial defibrillation threshold and pain perception. J Am Coll Cardiol 28: 695–699CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 1998

Authors and Affiliations

  • M. Santini
    • 1
  • C. Pandozi
    • 1
  • G. Gentilucci
    • 1
  • M. Villani
    • 1
  1. 1.Dipartimento delle Malattie del CuoreOspedale San Filippo NeriRomeItaly

Personalised recommendations